PenderFund Capital Management »

Phoenix Biotech Acquisition Class A shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5k 100 14.76

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
PAR Technology Corporation (PAR)
Burford Cap Ord Shs (BUR)
Sangoma Technologies Corp Com New (SANG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Nuveen Insd Dividend Advantage (NVG)
Docebo (DCBO)
Kkr & Co (KKR)
Morgan Stanley Emerging Markets Domestic (EDD)

View all positions for PenderFund Capital Management

Top funds holding Phoenix Biotech Acquisition Class A

Cantor Fitzgerald, L. P.
Walleye Trading Advisors
Berkley W R
Walleye Trading
Kestra Private Wealth Services
PenderFund Capital Management

View all funds holding Phoenix Biotech Acquisition Class A